Baveno VII – Renewing consensus in portal hypertension
2021 · Journal of Hepatology · 2,388 citations
https://doi.org/10.1016/j.jhep.2021.12.022
L
Lina Benajiba
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
180
Papers
3.9K
Citations
21
h-index
28
i10-index
Lina Benajiba is an academic researcher from Université Paris Cité. The author has contributed to research in topics: Acute Myeloid Leukemia Research & RNA Interference and Gene Delivery & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 21, co-authored 153 publications.
ORCID: 0000-0001-5440-1115Papers by this author
worksAmong classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
2021 · Blood Cancer Journal · 37 citations
https://doi.org/10.1038/s41408-021-00417-3
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape
2023 · Leukemia · 18 citations
https://doi.org/10.1038/s41375-023-01886-0
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells
2025 · EMBO Reports · 1 citations
https://doi.org/10.1038/s44319-025-00466-w
Supplementary Figure S5 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423524
Supplementary Figure S1 from INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26423536.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat